AFIB Acutus Medical
- 0.1447
- -0.0081-5.31%
- 0.0900
- -0.0547-37.80%
Acutus Medical News
12 Health Care Stocks Moving In Friday's After-Market Session
GainersNeuBase Therapeutics (NASDAQ:NBSE) stock increased by 11.1% to $0.45 during Friday's after-market session. The market value of their outstanding shares is at $1.6 million. Aptevo Therapeutics (
Express News | Acutus Medical Shares Are Trading Lower After Nasdaq Notified the Company That It Has Not Regained Compliance With Listing Rule 5550(a)(2)
Express News | Acutus Medical Inc -on April 30, Nasdaq Notified Co That It Has Not Regained Compliance With Listing Rule 5550(a)(2)
Express News | Earlier Announced, Acutus Medical Was Granted EU Patent #3294412 For "Localization System And Method Useful In The Acquisition And Analysis Of Cardiac Information"
Acutus Medical Full Year 2023 Earnings: US$0.41 Loss per Share (Vs US$1.40 Loss in FY 2022)
Acutus Medical GAAP EPS of -$2.81, Revenue of $7.2M
Acutus Medical 4Q Rev $2.4M >AFIB
Acutus Medical 4Q Rev $2.4M >AFIB
Acutus Medical: Due to Plan to Realign Resources to Support Left-Heart Access Distribution Business and Exit From Electrophysiology Mapping and Ablation Businesses, Co Will No Longer Provide Fincl Guidance >AFIB
Acutus Medical: Due to Plan to Realign Resources to Support Left-Heart Access Distribution Business and Exit From Electrophysiology Mapping and Ablation Businesses, Co Will No Longer Provide Fincl Gui
Press Release: Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB) today r
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersOntrak (NASDAQ:OTRK) shares increased by 97.6% to $0.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.3 million. Fusion Pharmaceuticals (NASDAQ:FUSN)
12 Health Care Stocks Moving In Monday's After-Market Session
GainersOntrak (NASDAQ:OTRK) stock increased by 61.0% to $0.31 during Monday's after-market session. The company's market cap stands at $8.4 million. Universe Pharmaceuticals (NASDAQ:UPC) stock rose 30
Express News | Acutus Medical Has Been Granted European Patent Number EP3294412 Titled "Localization System And Method Useful In The Acquisition And Analysis Of Cardiac Information (For Diagnosis And Treatment Of Cardiac Abnormalities)"
It's Down 29% But Acutus Medical, Inc. (NASDAQ:AFIB) Could Be Riskier Than It Looks
Acutus Medical, Inc. (NASDAQ:AFIB) shareholders won't be pleased to see that the share price has had a very rough month, dropping 29% and undoing the prior period's positive performance.
Express News | Acutus Medical Shares Are Trading Higher After the Company Was Granted European Patent Number EP3294399 Titled "Catheter System For Left Heart Access."
Express News | Acutus Medical Has Been Granted European Patent Number EP3294399 Titled "Catheter System For Left Heart Access"
Acutus Medical Faces Biotronik Contract Termination Dispute
Express News | Acutus Medical Said On February 2 Biotronik Sent A Notice Of Rescission And Termination To Company; Biotronik Rescinds And Terminates Bi-lateral Distribution Agreements
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersAgape ATP (NASDAQ:ATPC) shares rose 92.1% to $0.98 during Tuesday's pre-market session. The company's market cap stands at $75.5 million. Jin Medical International (NASDAQ:ZJYL) stock moved upw
12 Health Care Stocks Moving In Friday's Intraday Session
GainersCorbus Pharmaceuticals (NASDAQ:CRBP) shares moved upwards by 309.1% to $34.53 during Friday's regular session. The market value of their outstanding shares is at $152.7 million. Aclarion (NASDA
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersInspire Veterinary (NASDAQ:IVP) stock moved upwards by 37.5% to $0.26 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million. Tharimmune (NASDAQ
Analysis
Price Target
No Data
